Literature DB >> 412464

Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.

B H Minshew, H M Pollock, F D Schoenknecht, J C Sherris.   

Abstract

From July 1974 through June 1976, a number of isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa from the Burn Center exhibited a shift to smaller zone diameters with gentamicin than did isolates from the general hospital population. Although many had zone diameters >/=13 mm and would have been considered susceptible by this breakpoint, they were found to have minimal inhibitory concentrations (MICs) of >/=8 mug of gentamicin per ml by agar dilution testing. Zone diameters and MICs of gentamicin, tobramycin, and amikacin were subsequently compared for 168 isolates from both the Burn Center and general hospital. The results revealed many isolates that fell into presently used gentamicin- and tobramycin-"susceptible" categories by disk diffusion tests but were resistant by MIC. The data indicated that criteria for gentamicin disk diffusion testing should include an intermediate or indeterminate category, and that the limits of the intermediate category for tobramycin and amikacin should be expanded.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412464      PMCID: PMC430005          DOI: 10.1128/AAC.12.6.688

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.

Authors:  L B Reller; F D Schoenknecht; M A Kenny; J C Sherris
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

2.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

3.  Recent microbiological studies with gentamicin.

Authors:  J A Waitz; M J Weinstein
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

4.  Resistance of Pseudomonas aeruginosa to gentamicin and related aminoglycoside antibiotics.

Authors:  R K Holmes; B H Minshew; I K Gould; J P Sanford
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

5.  Cross-resistance of Pseudomonas to gentamicin and tobramycin.

Authors:  J L Brusch; M Barza; M G Bergeron; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

6.  Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.

Authors:  F A Drasar; W Farrell; J Maskell; J D Williams
Journal:  Br Med J       Date:  1976-11-27

Review 7.  Aspects of the pharmacology and toxicology of tobramycin in animals and humans.

Authors:  K S Israel; J S Welles; H R Black
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

8.  Transferrable resistance to tobramycin in Klebsiella pneumoniae and Enterobacter cloacae associated with enzymatic acetylation of tobramycin.

Authors:  B H Minshew; R K Holmes; J P Sanford; C R Baxter
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

9.  Role of ionic strength in salt antagonism of aminoglycoside action on Escherichia coli and Pseudomonas aeruginosa.

Authors:  W H Beggs; F A Andrews
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

10.  Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.

Authors:  K E Price; M D DeFuria; T A Pursiano
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

View more
  11 in total

1.  Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study.

Authors:  J A Washington; P K Yu; T L Gavan; F D Schoenknecht; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

2.  Comparison of direct and standard antimicrobial disk susceptibility testing for bacteria isolated from blood.

Authors:  S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

3.  Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982.

Authors:  B A Atkinson; V Lorian
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

4.  Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.

Authors:  I B Duncan; E Y Cheung; E V Haldane; F L Jackson; R D McNaughton; R A Morisset; M A Noble; R P Rennie; A R Ronald; J A Smith
Journal:  Can Med Assoc J       Date:  1981-05-01       Impact factor: 8.262

5.  Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa.

Authors:  H M Pollock; B H Minshew; M A Kenny; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

6.  Aminoglycoside resistance among blood culture isolates.

Authors:  P Huovinen; P Grönroos; E Herva; M L Katila; M L Klossner; O V Renkonen; P Toivanen
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

7.  Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.

Authors:  B F Woolfrey; J M Fox; C O Quall; R T Lally
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

Authors:  L F Joyce; J Downes; K Stockman; J H Andrew
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

9.  Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents.

Authors:  M Y Ma; E J Goldstein; M H Friedman; M S Anderson; M E Mulligan
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

10.  Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin.

Authors:  M A Kenny; H M Pollock; B H Minshew; E Casillas; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.